6MWT | 6-minute walk test |
ACCF | American College of Cardiology Foundation |
ACEI | angiotensin-converting enzyme inhibitor |
A-fib | atrial fibrillation |
AHA | American Heart Association |
AL | amyloid light-chain |
ALP | alkaline phosphatase |
ARB | angiotensin receptor blocker |
ARNI | angiotensin receptor blocker—neprilysin inhibitor |
ASO | antisense oligonucleotide |
BB | β-blocker |
BNP | brain natriuretic peptide |
CA | cardiac amyloidosis |
CIDP | chronic inflammatory demyelinating polyneuropathy |
CKD | chronic kidney disease |
CM | cardiomyopathy |
CMR | cardiac magnetic resonance |
CRT | cardiac resynchronization therapy |
CTS | carpal tunnel syndrome |
dFLC | difference between uninvolved and involved free light chain |
ECV | extracellular volume fraction |
EF | ejection fraction |
eGFR | estimated glomerular filtration rate |
EMB | endomyocardial biopsy |
FLC | free light chain |
GLS | global longitudinal peak systolic left ventricular strain |
HF | heart failure |
HFpEF | HF with preserved ejection fraction |
HFrEF | HF with reduced ejection fraction |
(HR)QOL | (health related) quality of life |
hs‐TnI | high‐sensitivity troponin I |
hs‐TnT | high‐sensitivity troponin T |
ICD | implantable cardiac defibrillator |
ISA | International Society of Amyloidosis |
IVS | intraventricular septum |
KCCQ | Kansas City Cardiomyopathy Questionnaire |
LGE | late gadolinium enhancement |
LV | left ventricular |
LVEF | LV ejection fraction |
LVH | LV hypertrophy |
MDV | Medical Data Vision |
MGUS | monoclonal gammopathy of undetermined significance |
MIBG | meta-iodobenzylguanidine |
NAC | National Amyloidosis Center (UK) |
NSAID | non-steroidal anti-inflammatory drug |
NT‐proBNP | N‐terminal pro‐B‐type natriuretic peptide |
NYHA | New York Heart Association |
PET | positron emission tomography |
PN | peripheral neuropathy |
PPM | permanent pacemaker |
PRO(Ms) | patient-related outcome (measures) |
PYP | pyrophosphate |
SAP | serum amyloid P component |
SCD | sudden cardiac death |
SF-36 | 36-Item Short Form Survey |
siRNA | small inhibitory RNA |
SQ | subcutaneous |
SVI | stroke volume index |
TAVR | transcatheter aortic valve replacement |
TnT | troponin T |
TUDCA | tauroursodeoxycholic acid |
⁹⁹ᵐTc‐PYP | ⁹⁹ᵐTechnetium‐pyrophosphate |
VKA | vitamin K antagonist |
VT | ventricular tachycardia |